- P&G Health, makers of Neurobion, embark on an effort to
help people 'Put Life Back in Their Hands' for an improved quality
of life.
- Launched on World Diabetes Day across 18 countries, the
campaign raises awareness on Peripheral Neuropathy in diabetes, and
the importance of early identification and timely
treatment.
SINGAPORE, Nov. 8, 2022 /PRNewswire/ -- Ahead of World
Diabetes Day 2022, P&G Health, announced it's 'Put Life Back
in Your Hands' campaign being commemorated across 18 countries
in Asia Pacific, Middle East, and Africa, to raise public awareness on the
connection between Peripheral Neuropathy and Diabetes, and the
importance of early identification and timely treatment.
With Diabetes Mellitus being the leading cause[2] of
Peripheral Neuropathy (PN), the increasing prevalence of PN is
closely linked to the rise in the number of diabetic patients. PN
including Diabetic Peripheral Neuropathy (DPN) is the result of
damage to the nerves impacting quality of life of people as they
are not able to go about their daily lives as comfortably. Symptoms
of peripheral neuropathy include numbness, tingling, prickling, and
burning sensations in the hands and feet. Besides diabetes
mellitus, B vitamins deficiencies and aging are other high-risk
factors leading to peripheral nerve damage.
FAST FACTS:
- In 2021, there were 393 million diabetic patients[3]
in the Asia Pacific, Middle East, and African regions projected to
rise to 603 million by 2045[3].
- With ~50%[1] of diabetic patients indicating that
they suffer from Peripheral Neuropathy, there will be an
exponential growth in the number of patients in these regions with
PN.
- Less than one-third of physicians recognize signs of DPN.
Undiagnosed cases contributing greatly to the high rates of
morbidity and mortality of diabetes[3]. Up to 50 % of
patients are asymptomatic and therefore often remain undiagnosed
and are at risk of insensate injury[4].
- If not diagnosed and treated early, DPN can develop into
neuropathic pain which has a tremendous impact on the quality of
life.
- To decrease the risk of DPN, regular screening, early detection
and patient education are crucial for optimal treatment
outcomes.
Aalok Agrawal, Senior
Vice-President, P&G Health, Asia, India,
Middle East & Africa said "As a
partner to International Diabetes Federation (IDF), P&G Health
is committed to continued efforts to raise awareness on Diabetes
and its associated complications including Peripheral Neuropathy
and Nerve Damage. Our 'Put Life Back in Your Hands' campaign is a
large-scale collective awareness effort across 18 countries with
consumers, healthcare professionals, pharmacists, medical and
partner organisations to highlight the everyday challenges
faced by people suffering from Peripheral Neuropathy, and the
importance of timely diagnoses and treatment for an improved
quality of life.
"With conditions such as diabetes and peripheral neuropathy
underdiagnosed and untreated in our region, platforms such as World
Diabetes Day also provide an opportunity for collective efforts on
raising awareness and education for improved treatment outcomes.
One such effort is P&G Health's 'Winning the Fight Against
Neuropathy in Diabetic Patients' forum which will bring together
globally renowned multidisciplinary medical experts with Healthcare
Professionals and Pharmacists from across Asia-Pacific, Middle
East, to share latest clinical guidance on diagnosing and
treating diabetic nerve damage," he added.
For more information on the 'Winning the Fight Against
Neuropathy in Diabetic Patients' forum, please write in to our
media contacts, or click here to register the webinar as healthcare
professional: WDDglobalwebinar
Disclaimer: Indications of Neurobion may
differ in different countries, please check with your local
healthcare professionals for more information.
About P&G Health:
P&G Health, the health care division of P&G company,
drives consumer-centric innovation to empower our consumers to live
healthier, and more vibrant lives. The P&G Health portfolio
includes leading brands in Respiratory with Vicks® and Nasivin®,
Pregnancy with Femibion® and Clearblue®, Oral Care with Crest® and
Oral-B®, Vitamins and Minerals Supplementation with Bion3®, Seven
Seas®, Evion® and Sangobion®, Digestive wellness with Metamucil®,
Prilosec OTC®, Pepto Bismol® and Align®, Nerve Care with Neurobion®
and Pain Relief with Dolo-Neurobion®.
About Procter & Gamble:
P&G serves consumers around the world with one of the
strongest portfolios of trusted, quality, leadership brands,
including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®,
Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head &
Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®,
Tide®, Vicks®, and Whisper®. The P&G community includes
operations in approximately 70 countries worldwide.
References:
1. Kumar S, et al. Laser Therapy 2016;25:
141–144
2. Landmann G. Ars Medici. 2013;1: 18-21
3. International Diabetes Federation. IDF
Diabetes Atlas. 10th edition; 2021.
4. Miranda-Massari JR, et al. Curr Clin
Pharmacol. 2011;6: 260–273.
Photo - https://mma.prnewswire.com/media/1939761/image_1.jpg
Photo -
https://mma.prnewswire.com/media/1939762/image_2.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/1-in-2-diabetics-suffer-from-peripheral-neuropathy1-during-their-lifetime-301670226.html